KATHERINE ZAMECKI-VEDDER, MD
Ophthalmic Plastic and Reconstructive Surgery Physician in DANBURY, Connecticut. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
KATHERINE ZAMECKI-VEDDER, MD reported a CMS MIPS final score of 94.2464/100 — above the 83.1 national average — and filed 1,068 Medicare Part D claims in 2023.
- 94.2464/100
- MIPS score · +11 vs avg
- 1K
- Part D claims, 2023
- 41%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
KATHERINE ZAMECKI-VEDDER, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
94 Top 25% higher than 75% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
KATHERINE ZAMECKI-VEDDER, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about KATHERINE ZAMECKI-VEDDER, MD?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Connecticut
How Ophthalmic Plastic and Reconstructive Surgery Physician compares to other specialties among Connecticut providers
Ophthalmic Plastic and Reconstructive Surgery Physician share within Connecticut
Ophthalmic Plastic and Reconstructive Surgery Physician is one of the more visible NUCC categories in Connecticut
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
KATHERINE ZAMECKI-VEDDER, MD's 2023 MIPS final score plotted against the Ophthalmic Plastic and Reconstructive Surgery Physician national average
- MIPS Final Score
- 94.2464/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Ophthalmic Plastic and Reconstructive Surgery Physician) — 94.2464/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Specialty volume Ophthalmic Plastic and Reconstructive Surgery Physician US NPIs
94.2464/100 MIPS final score — 11.1 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Ophthalmic Plastic and Reconstructive Surgery Physician. Quality dim: 78.2615.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
KATHERINE ZAMECKI-VEDDER, MD appears in the CMS NPPES registry as a Ophthalmic Plastic and Reconstructive Surgery Physician provider holding MD credentials at 69 SAND PIT RD, DANBURY, CT, 06810, with a listed phone of (203) 791-2020. NPI 1972764843 was issued on 06/23/2008. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ZAMECKI-VEDDER most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 1,068 prescription claims written by this provider, covering 526 Medicare beneficiaries and totaling roughly $780K in drug spend, split 59% brand-name and 41% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 94.2464/100 for the 2023 performance year (Quality 78.2615), compared with the national average of 83.1.
Ophthalmic Plastic and Reconstructive Surgery Physician is a narrow specialty nationwide, with 291 enrolled providers across 46 states and an average of 624 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1972764843 |
|---|---|
| Specialty | Ophthalmic Plastic and Reconstructive Surgery Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 06/23/2008 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm KATHERINE ZAMECKI-VEDDER, MD's current license status, disciplinary history, and board certifications with the Connecticut Department of Public Health in Connecticut before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Alternative Payment Model
Hospital and facility affiliations
Facilities where KATHERINE ZAMECKI-VEDDER, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for KATHERINE ZAMECKI-VEDDER, MD. Source: openpaymentsdata.cms.gov.
Total received
$473
Largest payer
SUN PHARMACEUTICAL INDUSTRIES INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Brand-heavy
59% brand-name claims vs 41% generic, on 1,068 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 1,520
- Total Day Supply
- 34,981
- Brand vs Generic
- 59% brand / 41% generic
- Brand Drug Cost
- $755K
- Generic Drug Cost
- $24K
- Antibiotic Claims
- 48
Patient Demographics
- Average Patient Age
- 75.8 years
- Avg HCC Risk Score
- 1.09
- Gender Split
- 67% female / 33% male
- Age Distribution
- <65: 21, 65-74: 216, 75-84: 212, 85+: 77
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What KATHERINE ZAMECKI-VEDDER, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Neomycin-Polymyxin…
Neomycin-Polymyxin-Dexameth
262 claims
- Tobramycin-Dexamet…
Tobramycin-Dexamethasone
109 claims
- Xiidra 94
Xiidra
94 claims
- Restasis 85
Restasis
85 claims
- Erythromycin 84
Erythromycin
84 claims
- Loteprednol Etabon… 82
Loteprednol Etabonate
82 claims
- Prednisolone Acetate 63
Prednisolone Acetate
63 claims
- Doxycycline Hyclate 37
Doxycycline Hyclate
37 claims
| Drug | Claims |
|---|---|
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 262 |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 109 |
| Xiidra Lifitegrast | 94 |
| Restasis Cyclosporine | 85 |
| Erythromycin Erythromycin Base | 84 |
| Loteprednol Etabonate | 82 |
| Prednisolone Acetate | 63 |
| Doxycycline Hyclate | 37 |
| Latanoprost | 34 |
| Cyclosporine | 27 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Ophthalmic Plastic and Reconstructive Surgery Physician Overview
How KATHERINE ZAMECKI-VEDDER, MD fits within the Ophthalmic Plastic and Reconstructive Surgery Physician landscape nationally.
KATHERINE ZAMECKI-VEDDER, MD's 1,068 claims are above the specialty average of 624.
Nearby Ophthalmic Plastic and Reconstructive Surgery Physician Providers in Connecticut
Other clinicians with the same primary specialty enrolled in Connecticut, drawn from the same CMS NPPES roster as ZAMECKI-VEDDER.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Connecticut
Frequently Asked Questions
What is KATHERINE ZAMECKI-VEDDER, MD's specialty? ▼
How much does KATHERINE ZAMECKI-VEDDER, MD prescribe under Medicare Part D? ▼
What is KATHERINE ZAMECKI-VEDDER, MD's Medicare quality score? ▼
Where is KATHERINE ZAMECKI-VEDDER, MD located? ▼
What is KATHERINE ZAMECKI-VEDDER, MD's NPI number? ▼
Does KATHERINE ZAMECKI-VEDDER, MD prescribe more brand-name or generic drugs? ▼
How many Ophthalmic Plastic and Reconstructive Surgery Physician providers are there in the US? ▼
What drugs does KATHERINE ZAMECKI-VEDDER, MD prescribe most often? ▼
Does KATHERINE ZAMECKI-VEDDER, MD accept Medicare? ▼
How can I verify KATHERINE ZAMECKI-VEDDER, MD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology